Intelimedi

  IntelliMedi System – BioChip for Man

Monitoring Real Time Biological Functions in Vivo

 

  IntelliMedi designs a platform for in vivo monitoring, real time, biological functions in

Man, via an implanted chip. 
  

 The dedicated chip is designed to detects specific signals by alterations of electro-

magnetic resonance or photometric signals and alike.

IntelliMedi Ltd is a start-up, founded (September 2006) by David G. Mendes MD,

Engineer Emanuel Mendes and Mrs. Ruth Beer, that acquired the entire knowled

ge (USA Patents) and know-how (6 years experience) of IntelliJoint Systems Ltd
 
and develops further patents (PCT) in its pipeline
.

Based on results of laboratory and experimental (sheep and pigs) studies IntelliMedi

 plans the start of Clinical studies in 2008
.

Private and Chief Scientist investments are the basic finances.

 IntelliMedi sensor  

 

 The Need

 Availability of monitoring system is required for people with a variety of health problems such

         as Metabolic and Hormonal disorders, Cardio-Vascular and following Surgical

procedures, where early diagnosis of deviation and imbalance such as biochemical or

biomechanical will save lives and finances.

Likewise, availability of GPS like monitoring

g system is long time needed for conditions such as Alzheimer, mentally retarded and

a like. 

 Application  

 Starting with first application in bone surgery IntelliMedi has developed   

A SYSTEM to MONITOR HEALING' that competes and supplements conventional

 Imaging Modalities.

X-rays, CT, MRI, Isotopes and Ultrasound are of low resolution, observer dependent,

 delayed results, less efficient with complex anatomic structures and presence of metallic

objects and some carries substantial radiation risk.

The present system is designed for clinical use in bone surgery monitoring healing of

 Sternotomy in Heart and Chest surgery.

By early detection of deviation from expected normal progress following surgery, it

 distinguishes success from failure and overcome the major limitation of Imaging

 Modalities.

The benefit of early diagnosis of a failing procedure is in taking the appropriate medical

 or surgical measures prior to having an imminent disaster

For the physician it provides the option to initiate early treatment of choice, either medical

or surgical and offers a feed back mechanism by evaluating results of treatment using

same system.

For the patients it provides up dated information in real time at home or in clinic through

Telemetry.

Technology

 A system of wireless electro-magnetic sensors are implanted in tissue for dynamic

measurements of displacements in vivo, in real time.

Radio-frequency data obtained from the sensors through an external antenna are

converted by dedicated software into distances and displacements.

With resolution of circa 50 micron, the sensors monitor the progress of bone healing and

supply early information unobtainable from X-rays and other imaging modalities.

The sensors are sealed and biocompatible, inert, robust, passive with no source of

energy,

no maintenance no replacement and are therefore suitable for very long-term medical

and surgical applications.

Their shape and size are modified to fit the required application and can be further

miniaturized by appropriate technology.

The system was successfully tested for efficacy and safety in models of animal

 experimental surgery (sheep and pigs).

Further Bony Application

 Future applications are in a variety of procedures in Orthopaedic surgery such as

monitoring Spinfusion, Fracture healing and performance of Artificial Joints Implants.

Verichip, USA. Implantable electro-magnetic chips in subcutanous tissue in

 Man.Cardiomems, USA. Implantable electro-magnetic chips for measurements of

 pressure.RSA, Sweden. Implantable tantalum spheres in bone for X rays measurements.

Market

Based on projected Revenues from: Fee for service, sell of sensors and sell of hard and

 soft ware following 2% market penetration in 1 year the company net earning is in the

.black